Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (6)

  1. Anton Shkundin, Angelos Halaris. IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions. JPM 2024;14:488
    https://doi.org/10.3390/jpm14050488
  2. Aakanksha Singh, Gurraj Singh, Satwant Singh, Sana Elham Kazi, Manpreet Gill. N-acetylcysteine in the Treatment of Internet Gaming Disorder. 2022
    https://doi.org/10.7759/cureus.28662
  3. Fateme Padoei, Peyman Mamsharifi, Pooya Hazegh, Homa Boroumand, Fatemeh Ostadmohammady, Samira Abbaszadeh‐Mashkani, Hamid Reza Banafshe, Amir Hassan Matini, Amir Ghaderi, Somayeh Ghadami Dehkohneh. The therapeutic effect of N‐acetylcysteine as an add‐on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double‐blind, placebo‐controlled clinical trial. Brain and Behavior 2023;13
    https://doi.org/10.1002/brb3.2823
  4. Richard C. J. Bradlow, Michael Berk, Peter W. Kalivas, Sudie E. Back, Richard A. Kanaan. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs 2022;36:451
    https://doi.org/10.1007/s40263-022-00907-3
  5. Ellen D. Herbst, David L. Pennington, Brian Borsari, Jennifer Manuel, Matthew Yalch, Eric Alcid, Madeline Martinez Rivas, Joannalyn Delacruz, Nathan Rossi, Brianna Garcia, Natalie Wong, Steven L. Batki. N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial. Contemporary Clinical Trials 2023;131:107250
    https://doi.org/10.1016/j.cct.2023.107250
  6. Seetal Dodd, Jodie Harper, Michael Berk. Current Pharmacotherapies for Smoking Cessation and Promising Emerging Drugs. CRCEP 2024;19:259
    https://doi.org/10.2174/0127724328274939231121114142